CSC Adds New Board Members

November 30, 2017

Cancer Support Community Announces Three New Board Members

WASHINGTON, D.C. — The Cancer Support Community (CSC), an international nonprofit organization, is pleased to announce the addition of three new members to its Headquarters Board of Directors: Bjoern Albrecht, Jing Liang, and Lynne O’Brien. The Board provides leadership and guidance for carrying out CSC’s mission to ensure that no one faces cancer alone.

“Bjoern, Jing, and Lynne bring such a diverse set of experiences and insights from the policy world and the private sector,” said Kim Thiboldeaux, CEO of the Cancer Support Community. “They’re joining our stellar Board, which is committed to advancing innovative ways to help us serve more patients and their loved ones.”

Bjorn Albrecht

Bjorn Albrecht

Bjoern Albrecht is a partner at McKinsey & Company, a worldwide management consulting firm. He works with pharmaceutical and biotech companies, health systems, and providers on cancer-related topics. He leads the McKinsey Cancer Center, coordinating all of McKinsey’s work on cancer-related topics globally, and is also a leader in the Pharmaceuticals & Medical Products Practice in Europe. Albrecht manages the annual “McKinsey Cancer Congress Series” Satellite Symposium at the American Society of Clinical Oncology. He holds a Ph.D. in molecular, cellular, and developmental biology from The Ohio State University Comprehensive Cancer Center and a BS in biochemistry and molecular biology from the University of Hamburg.


Jing Liang

Jing Liang

Jing Liang is an entrepreneur and management consultant. He is the co-founder and managing partner of Umbrex, a global community of independent, top-tier management consultants. He also founded and serves as the CEO of Attenua, a biotech developing non-narcotic prescription treatments for chronic cough. He was a co-founder of Storelli Sports, the only brand devoted exclusively to the design and manufacture of head-to-toe soccer protection at every position. He holds a Ph.D. in Molecular Biophysics from Johns Hopkins University and a BS in Molecular Biology & Biochemistry from Penn State University.


Lynne O’Brien

Lynne O'Brien

Lynne O’Brien worked as a Policy Analyst with the White House Cancer Moonshot office under former Vice President Joe Biden. Previously, she worked as director of the Washington Government Affairs Office of DuPont Merck and DuPont Pharmaceuticals, working with members of Congress on issues involving the U.S. Food and Drug Administration, tax legislation, and health care reform. She started her career in DC with Williams and Jensen, a lobbying/law firm in Washington, DC, focusing on health care clients. O’Brien is also on the national board of the Leukemia, Lymphoma Society (LLS) and is a trustee of The Potomac School in McLean, Virginia. O'Brien graduated cum laude from Princeton with an A.B. in political science and earned her law degree from Georgetown University Law Center. She is also a blood cancer survivor who finished treatment for chronic lymphocytic leukemia in 2016.